176 related articles for article (PubMed ID: 36293074)
81. P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation.
Nagai J; Balestrieri B; Fanning LB; Kyin T; Cirka H; Lin J; Idzko M; Zech A; Kim EY; Brennan PJ; Boyce JA
J Clin Invest; 2019 Dec; 129(12):5169-5186. PubMed ID: 31638598
[TBL] [Abstract][Full Text] [Related]
82. Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in rats.
Neves JS; Lima LM; Fraga CA; Barreiro EJ; Miranda AL; Diaz BL; Balduino A; Siqueira Rde A; e Silva PM; Martins MA
Eur J Pharmacol; 2005 Mar; 511(2-3):219-27. PubMed ID: 15792791
[TBL] [Abstract][Full Text] [Related]
83. Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):995-1001. PubMed ID: 29032198
[TBL] [Abstract][Full Text] [Related]
84. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
85. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
86. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
87. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract][Full Text] [Related]
88. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
[TBL] [Abstract][Full Text] [Related]
89. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
Yu SY; Zhang XY; Wang XR; Xu DM; Chen L; Zhang LH; Fang SH; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2014 Jan; 35(1):33-40. PubMed ID: 24141567
[TBL] [Abstract][Full Text] [Related]
90. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
91. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
92. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
Luo KW; Ko CH; Yue GG; Gao S; Lee JK; Li G; Fung KP; Leung PC; Evdokiou A; Lau CB
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1025-36. PubMed ID: 25431338
[TBL] [Abstract][Full Text] [Related]
93. LTRA inhibition of exercise-induced bronchoconstriction.
Kraft M
Postgrad Med; 2000 Sep; 108(4 Suppl):32-9. PubMed ID: 19667531
[TBL] [Abstract][Full Text] [Related]
94. Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis.
Luo S; Feng J; Xiao L; Guo L; Deng L; Du Z; Xue Y; Song X; Sun X; Zhang Z; Fu Y; Gong T
Biomaterials; 2020 Aug; 249():120055. PubMed ID: 32315863
[TBL] [Abstract][Full Text] [Related]
95. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
Smith LJ; Hanby LA; Lavins BJ; Simonson SG
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
[TBL] [Abstract][Full Text] [Related]
96. Erratum to "Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic".
FASEB J; 2024 Jan; 38(1):e23393. PubMed ID: 38140910
[No Abstract] [Full Text] [Related]
97. Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung.
Saier L; Ribeiro J; Daunizeau T; Houssin A; Ichim G; Barette C; Bouazza L; Peyruchaud O
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293074
[TBL] [Abstract][Full Text] [Related]
98. Cysteinyl Leukotriene Pathway and Cancer.
Tsai MJ; Chang WA; Chuang CH; Wu KL; Cheng CH; Sheu CC; Hsu YL; Hung JY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008546
[TBL] [Abstract][Full Text] [Related]
99. Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation.
Zhou X; Cai J; Liu W; Wu X; Gao C
Biomed Pharmacother; 2019 Mar; 111():452-459. PubMed ID: 30594784
[TBL] [Abstract][Full Text] [Related]
100. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.
Wenzel J; Zeisig R; Fichtner I
Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
